Paeoniflorin reduces neomycin-induced ototoxicity in hair cells by suppression of reactive oxygen species generation and extracellularly regulated kinase signalization

Toxicol Lett. 2018 Mar 15:285:9-19. doi: 10.1016/j.toxlet.2017.12.026. Epub 2017 Dec 29.

Abstract

The present study was designed to investigate the effect of paeoniflorin (PF) on neomycin-induced ototoxicity in hair cells (HCs). Here, we took advantage of C57BL/6 mice and cochlear explants culture to determine the role of PF in vivo and in vitro. We demonstrated that neomycin exposure induced severe hearing loss and HC damage, which was mediated by activated mitochondrial apoptosis pathway, promoted extracellular signal-regulated kinase (ERK) signaling as well as enhanced reactive oxygen species (ROS) generation in HCs. Interestingly, we found that PF pretreatment significantly alleviated neomycin-induced hearing loss, attenuated HC injury and decreased HC apoptosis caused by neomycin. Mechanistic studies revealed that PF could decrease cellular ROS levels, suppress the activation of ERK signaling and, subsequently, mitigate the imbalance of mitochondrial apoptotic pathway, thus protecting HCs from neomycin-induced apoptosis. This study indicates that PF may serve as an antioxidative and anti-apoptotic agent to prevent hearing loss caused by neomycin.

Keywords: Apoptosis; MAPK; Neomycin; Ototoxicity; Paeoniflorin; ROS.

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Apoptosis / drug effects
  • Cells, Cultured
  • Evoked Potentials, Auditory, Brain Stem / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Glucosides / administration & dosage
  • Glucosides / therapeutic use*
  • Hair Cells, Auditory / drug effects*
  • Hair Cells, Auditory / metabolism
  • Hair Cells, Auditory / pathology
  • Hearing Loss / chemically induced
  • Hearing Loss / metabolism
  • Hearing Loss / pathology
  • Hearing Loss / prevention & control*
  • Mice, Inbred C57BL
  • Mitochondria / drug effects
  • Mitochondria / pathology
  • Monoterpenes / administration & dosage
  • Monoterpenes / therapeutic use*
  • Neomycin / toxicity*
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction

Substances

  • Antioxidants
  • Glucosides
  • Monoterpenes
  • Reactive Oxygen Species
  • peoniflorin
  • Extracellular Signal-Regulated MAP Kinases
  • Neomycin